Clinical trial
Hypofractionated Radiotherapy (55 Gy/16 Fractions/4 Weeks) for Localized…
NCT00129025 · Alberta Health services, Other · Completed
Key facts
| NCT number | NCT00129025 |
|---|---|
| Title | Hypofractionated Radiotherapy (55 Gy/16 Fractions/4 Weeks) for Localized Prostate Cancer |
| Official title | A Phase I/II Study of Escalated-Dose Short-Course Hypofractionated Radiotherapy (55 Gy/16 Fractions/4 Weeks) for Localized Prostate Cancer |
| Lead sponsor | Alberta Health services, Other |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Procedure |
| Interventions | Hypofractionated radiotherapy |
| Enrollment | 35 |
| Start date | Oct 1, 2004 |
| Primary completion | Dec 1, 2006 |
| Completion | Dec 1, 2006 |
| First posted | Aug 11, 2005 |
| Last update posted | Oct 10, 2011 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: